Importantly, IL-17A levels and IL-17+ lymphocyte infiltration are increased in SSc patients, promoting chemokine and adhesion molecule expression in endothelial cells and enhancing T cell adhesion via the ERK signaling pathway [14]. The gene discussed is IL17A; the disease is systemic sclerosis.